Anti-SORCS2 monoclonal antibody

Pre-made anti-SORCS2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SORCS2/SORCS2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1788-Ab-1/ GM-Tg-hg-IP1788-Ab-2Anti-Human SORCS2 monoclonal antibodyHuman
GM-Tg-rg-IP1788-Ab-1/ GM-Tg-rg-IP1788-Ab-2Anti-Rat SORCS2 monoclonal antibodyRat
GM-Tg-mg-IP1788-Ab-1/ GM-Tg-mg-IP1788-Ab-2Anti-Mouse SORCS2 monoclonal antibodyMouse
GM-Tg-cynog-IP1788-Ab-1/ GM-Tg-cynog-IP1788-Ab-2Anti-Cynomolgus/ Rhesus macaque SORCS2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1788-Ab-1/ GM-Tg-felg-IP1788-Ab-2Anti-Feline SORCS2 monoclonal antibodyFeline
GM-Tg-cang-IP1788-Ab-1/ GM-Tg-cang-IP1788-Ab-2Anti-Canine SORCS2 monoclonal antibodyCanine
GM-Tg-bovg-IP1788-Ab-1/ GM-Tg-bovg-IP1788-Ab-2Anti-Bovine SORCS2 monoclonal antibodyBovine
GM-Tg-equg-IP1788-Ab-1/ GM-Tg-equg-IP1788-Ab-2Anti-Equine SORCS2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1788-Ab-1/ GM-Tg-hg-IP1788-Ab-2; GM-Tg-rg-IP1788-Ab-1/ GM-Tg-rg-IP1788-Ab-2;
GM-Tg-mg-IP1788-Ab-1/ GM-Tg-mg-IP1788-Ab-2; GM-Tg-cynog-IP1788-Ab-1/ GM-Tg-cynog-IP1788-Ab-2;
GM-Tg-felg-IP1788-Ab-1/ GM-Tg-felg-IP1788-Ab-2; GM-Tg-cang-IP1788-Ab-1/ GM-Tg-cang-IP1788-Ab-2;
GM-Tg-bovg-IP1788-Ab-1/ GM-Tg-bovg-IP1788-Ab-2; GM-Tg-equg-IP1788-Ab-1/ GM-Tg-equg-IP1788-Ab-2
Products NameAnti-SORCS2 monoclonal antibody
Formatmab
Target NameSORCS2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SORCS2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1788-Ag-1Recombinant multi-species SORC2/ SORCS2 protein


    Target information

    Target IDGM-IP1788
    Target NameSORCS2
    Gene ID57537,81840,305438,100423846,488785,101089766,618257,100070344
    Gene Symbol and SynonymsmKIAA1329,SORCS2
    Uniprot AccessionQ96PQ0
    Uniprot Entry NameSORC2_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000184985
    Target ClassificationN/A

    The target: SORCS2, gene name: SORCS2, also named as . This gene encodes one family member of vacuolar protein sorting 10 (VPS10) domain-containing receptor proteins. The VPS10 domain name comes from the yeast carboxypeptidase Y sorting receptor Vps10 protein. Members of this gene family are large with many exons but the CDS lengths are usually less than 3700 nt. Very large introns typically separate the exons encoding the VPS10 domain; the remaining exons are separated by much smaller-sized introns. These genes are strongly expressed in the central nervous system. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.